FDA Regulations Training Overview

AI/ ML will revolutionize medicine by making diagnosis and treatment more accessible and more effective. FDA has regulated medical device software by means of regulation and guidance’s for years, however, AI/ML programs fall outside the scope of these regulations and guidance’s. This happens because FDA approves the final, validated version of the software. The point of AI/ML is to learn and update following deployment using real world data to improve performance. Thus the field version of the software is no longer the validated approved version.

This training will address the current regulatory requirements, how they don’t control AI/ML adequately, and approaches FDA is considering for regulation in the near future. Development personnel should understand these concepts because, with some modifications, they will become regulations.

 It is not clear how to get AI/ML programs approved. Following discussion of possible future regulation, we will discuss, based on recently approved De Novo applications, how to get your AI/ML program approved now.

 Necessary submission documentation will be explained.

 This webinar is not a programming course but will explain the present and future regulatory requirements for AI/ML. Attendees will receive a multipage outline and checklist

Why Should You Attend

It is not clear how to get AI/ML programs approved. The current regulatory requirements don’t control AI/ML adequately.

We will discuss the approaches FDA is considering for regulation in the near future and how to get your AI/ML program approved by FDA now. Necessary submission documentation will be explained

 Attendees will receive a multipage outline and checklist

Webinar Takeaway

  • Total product life cycle approach to AI/ ML design
  • Application of FDA software Pre Cert program to AI/ ML
  • FDA discussion paper on AI/ML
  • Database management
  • QC of datasets
  • Algorithm updating
  • Reference standard development
  • Standalone performance testing
  • Clinical performance testing
  • Data enrichment
  • Emphasis on “explainability”
  • Additional labeling requirements
  • Cybersecurity

Who Will Benefit

This online training has been developed and is intended for professionals in the Medical Device and diagnostic industries. It will be especially beneficial to personnel working in the following areas and positions:

  • Software Engineers
  • Engineers
  • Quality Assurance
  • Regulatory
  • Marketing
  • Management
Faculty Edwin Waldbusser

Edwin Waldbusser

Edwin Waldbusser is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the US and internationally in the areas of design control, risk analysis and software validation for the past 12 years. Mr. Waldbusser has a BS in Mechanical Engineering and an MBA. He is a Lloyds of London certified ISO 9000 Lead Auditor and a member of the Thomson Reuters Expert Witness network.

Choose a Purchase Option


$299

Recorded Access Single Participant

You'll have 12 month single user access to log-in for an archived recording of the entire 60-minute webinar, including the Q&A period . You can log in any time of day or night. You'll also receive all presentation materials, plus an audio recording and transcript for the entire session. Delivery is approximately 48 hours after the session

$499

Recorded Access Corporate Group

You'll have 12 month group access to log-in for an archived recording of the entire 60-minute webinar, including the Q&A period . You can log in any time of day or night. You'll also receive all presentation materials, plus an audio recording and transcript for the entire session. Delivery is approximately 48 hours after the session

$999

Purchase Using Webinar All-Access Pass

(One user get unlimited access to all upcoming and recorded webinars (350+) for one year)